From Medical Innovation to Sociopolitical Crisis: How Racialized Medicine Has Shifted the Scope of Racial Discourse and its Social Consequences

Using a case study of a congestive heart failure medication, BiDil, patented in 2005 for use only in African Americans, I attempt to understand and analyze how the movement of racialized medicine has informed and effected American understandings of race, racial identity, and health.